{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:28:33Z","timestamp":1740162513812,"version":"3.37.3"},"reference-count":32,"publisher":"Pensoft Publishers","issue":"1","license":[{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["IMA Fungus"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Members of the genus <jats:italic>Cryptococcus<\/jats:italic> are the causative agents of cryptococcal meningitis, a disease mainly associated with HIV-induced immunosuppression. Patients with cryptococcal meningitis are at a serious risk of death. Most patients suffering from cryptococcosis belong to neglected populations. With reduced support for research, new therapies are unlikely to emerge. In this essay, we used the Policy Cures\/G-finder platform as a reference database for funding research on cryptococcal disease. Funding for cryptococcal research started being tracked by G-finder in 2013 and has continued to appear in the annual reports ever since. In total, 15 institutions were reported as major funders for research on cryptococcal disease over the years. The US National Institutes of Health (NIH) was the main funder, followed by the UK's Wellcome Trust. The annual analysis suggested slow yearly growth in funding from 2013 to 2021. The development of new tools to prevent and fight cryptococcal disease is urgent but requires improved funding.<\/jats:p>","DOI":"10.1186\/s43008-023-00133-6","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:05:30Z","timestamp":1709337930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Funding for research on cryptococcal disease: an analysis based on the G-finder report"],"prefix":"10.3897","volume":"15","author":[{"given":"Iraine","family":"Duarte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-3439","authenticated-orcid":false,"given":"Marcio L.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2258","published-online":{"date-parts":[[2024,3,2]]},"reference":[{"key":"133_CR1","doi-asserted-by":"crossref","unstructured":"Bangert M, Molyneux DH, Lindsay SW, Fitzpatrick C, Engels D. (2017) The cross-cutting contribution of the end of neglected tropical diseases to the sustainable development goals. Infect Dis Poverty. BioMed Central Ltd.","DOI":"10.1186\/s40249-017-0288-0"},{"key":"133_CR2","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/mmi.14565","volume":"114","author":"A Bermas","year":"2020","unstructured":"Bermas A, Geddes-McAlister J (2020) Combatting the evolution of antifungal resistance in Cryptococcus neoformans. Mol Microbiol 114:721\u2013734","journal-title":"Mol Microbiol"},{"issue":"5","key":"133_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/myc.12747","volume":"61","author":"F Bongomin","year":"2018","unstructured":"Bongomin F, Oladele RO, Gago S, Moore CB, Richardson MD (2018) A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species. Mycoses 61(5):290\u2013297","journal-title":"Mycoses"},{"key":"133_CR4","doi-asserted-by":"crossref","unstructured":"Boyer-Chammard T, Temfack E, Alanio A, Jarvis JN, Harrison TS, Lortholary O. Recent advances in managing HIV-associated cryptococcal meningitis [version 1; peer review: 2 approved]. F1000Res. F1000 Research Ltd; 2019.","DOI":"10.12688\/f1000research.17673.1"},{"key":"133_CR5","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2147\/HIV.S328362","volume":"13","author":"M Dembelu","year":"2021","unstructured":"Dembelu M, Woseneleh T (2021) Prevalence of and factors associated with reoccurrence of opportunistic infections among adult hiv\/aids patients attending the art clinic at public health facilities in arba minch town, southern Ethiopia. HIV\/AIDS - Res Palliative Care 13:867\u2013876","journal-title":"HIV\/AIDS - Res Palliative Care"},{"issue":"10","key":"133_CR6","first-page":"1382","volume":"30","author":"ST Denham","year":"2022","unstructured":"Denham ST, Brammer B, Chung KY, Wambaugh MA, Bednarek JM, Guo L et al (2022) A dissemination-prone morphotype enhances extrapulmonary organ entry by Cryptococcus neoformans Cell Host Microbe. Cell Press 30(10):1382\u20131400","journal-title":"Cell Press"},{"issue":"01","key":"133_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40249-020-0630-9","volume":"9","author":"D Engels","year":"2020","unstructured":"Engels D, Zhou XN (2020) Neglected tropical diseases: an effective global response to local poverty-related disease priorities. Infect Dis Poverty 9(01):9\u201317","journal-title":"Infect Dis Poverty"},{"key":"133_CR8","doi-asserted-by":"publisher","DOI":"10.1590\/0074-02760170554","author":"C Firacative","year":"2018","unstructured":"Firacative C, Lizarazo J, Illnait-Zaragoz\u00ed MT, Casta\u00f1eda E, Arechavala A, C\u00f3rdoba S et al (2018) The status of cryptococcosis in latin America. Mem Inst Oswaldo Cruz. https:\/\/doi.org\/10.1590\/0074-02760170554","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"133_CR9","doi-asserted-by":"crossref","unstructured":"Godinho RMC, Oliveira DL, Albuquerque PC, Dutra FF, De Almeida-Paes R, Rodrigues ML, et al. (2017) Cryptococcus and cryptococcosis. Current Progress in Medical Mycology.","DOI":"10.1007\/978-3-319-64113-3_6"},{"issue":"4","key":"133_CR10","first-page":"e00238","volume":"2","author":"F Hagen","year":"2017","unstructured":"Hagen F, Lumbsch HT, Arsic Arsenijevic V, Badali H, Bertout S, Billmyre RB et al (2017) Importance of resolving fungal nomenclature: the case of multiple pathogenic species in the cryptococcus genus mSphere. Am Soc Microbiol 2(4):e00238","journal-title":"Am Soc Microbiol"},{"issue":"8","key":"133_CR11","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","volume":"7","author":"M Hoenigl","year":"2022","unstructured":"Hoenigl M, Seidel D, Sprute R, Cunha C, Oliverio M, Goldman GH et al (2022) COVID-19-associated fungal infections. Nat Microbiol 7(8):1127\u20131140","journal-title":"Nat Microbiol"},{"issue":"12","key":"133_CR12","first-page":"1109","volume":"386","author":"JN Jarvis","year":"2022","unstructured":"Jarvis JN, Lawrence DS, Meya DB, Kagimu E, Kasibante J, Mpoza E et al (2022) Single-dose liposomal amphotericin B treatment for cryptococcal meningitis New England. J Med 386(12):1109\u20131120","journal-title":"J Med"},{"issue":"3","key":"133_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.imj.2022.08.006","volume":"1","author":"S Lahiri","year":"2022","unstructured":"Lahiri S, Chandrashekar N (2022) Advanced approach for antifungal susceptibility and characterization of resistance properties in clinical and environmental isolates of Cryptococcus species complex. Infectious Med 1(3):147\u2013153","journal-title":"Infectious Med"},{"key":"133_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.12688\/wellcomeopenres.16776.1","volume":"6","author":"B Larson","year":"2021","unstructured":"Larson B, Shroufi A, Muthoga C, Oladele R, Rajasingham R, Jordan A et al (2021) Induction-phase treatment costs for cryptococcal meningitis in high HIV-burden African countries: new opportunities with lower costs. Wellcome Open Res 6:140","journal-title":"Wellcome Open Res"},{"key":"133_CR15","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3389\/fmicb.2020.01837","volume":"11","author":"Y Li","year":"2020","unstructured":"Li Y, Zou M, Yin J, Liu Z, Lu B (2020) Microbiological, epidemiological, and clinical characteristics of patients with cryptococcal meningitis at a tertiary hospital in China: a 6-year retrospective analysis. Front Microbiol 11:1837","journal-title":"Front Microbiol"},{"issue":"4","key":"133_CR16","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/S1473-3099(18)30493-6","volume":"19","author":"A Loyse","year":"2019","unstructured":"Loyse A, Burry J, Cohn J, Ford N, Chiller T, Ribeiro I et al (2019) Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries. Lancet Infect Dis 19(4):e143\u2013e147","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"133_CR17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s13225-022-00510-3","volume":"116","author":"A Mapook","year":"2022","unstructured":"Mapook A, Hyde KD, Hassan K, Kemkuignou BM, \u010cmokov\u00e1 A, Surup F et al (2022) Ten decadal advances in fungal biology leading towards human well-being. Fungal Divers 116(1):547\u2013614","journal-title":"Fungal Divers"},{"issue":"11","key":"133_CR18","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","volume":"378","author":"SF Molloy","year":"2018","unstructured":"Molloy SF, Kanyama C, Heyderman RS, Loyse A, Kouanfack C, Chanda D et al (2018) Antifungal combinations for treatment of cryptococcal meningitis in Africa. New England J Med 378(11):1004\u20131017","journal-title":"New England J Med"},{"key":"133_CR19","first-page":"e170391","volume":"113","author":"A Mourad","year":"2018","unstructured":"Mourad A, Perfect JR (2018) The war on cryptococcosis: a review of the antifungal arsenal Mem Inst Oswaldo Cruz. Fundacao Oswaldo Cruz 113:e170391","journal-title":"Fundacao Oswaldo Cruz"},{"key":"133_CR20","doi-asserted-by":"crossref","unstructured":"Okwir M, Link A, Rhein J, Obbo JS, Okello J, Nabongo B, et al. (2022) High Burden of Cryptococcal Meningitis among Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-Infected Patients in Northern Uganda in the Era of \u201ctest and Treat\u201d: Implications for Cryptococcal Screening Programs. Open Forum Infect Dis. Oxford University Press; 9(2).","DOI":"10.1093\/ofid\/ofac004"},{"issue":"11","key":"133_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/ofid\/ofy267","volume":"5","author":"RKK Patel","year":"2018","unstructured":"Patel RKK, Leeme T, Azzo C, Tlhako N, Tsholo K, Tawanana EO et al (2018) High mortality in HIV-associated cryptococcal meningitis patients treated with amphotericin B-based therapy under routine care conditions in Africa. Open Forum Infect Dis 5(11):267","journal-title":"Open Forum Infect Dis"},{"key":"133_CR22","unstructured":"Policy Cures Research. G-FINDER data portal: tracking funding for global health R&D. https:\/\/gfinderdata.policycuresresearch.org. 2022."},{"issue":"12","key":"133_CR23","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/S1473-3099(22)00499-6","volume":"22","author":"R Rajasingham","year":"2022","unstructured":"Rajasingham R, Govender NP, Jordan A, Loyse A, Shroufi A, Denning DW et al (2022) The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis 22(12):1748\u20131755","journal-title":"Lancet Infect Dis"},{"key":"133_CR24","doi-asserted-by":"publisher","first-page":"105521","DOI":"10.1016\/j.micpath.2022.105521","volume":"166","author":"SS Rathore","year":"2022","unstructured":"Rathore SS, Sathiyamoorthy J, Lalitha C, Ramakrishnan J (2022) A holistic review on Cryptococcus neoformans. Microb Pathog 166:105521","journal-title":"Microb Pathog"},{"issue":"4","key":"133_CR25","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s15010-022-01805-y","volume":"50","author":"D Regalla","year":"2022","unstructured":"Regalla D, VanNatta M, Alam M, Malek AE (2022) COVID-19-associated Cryptococcus infection (CACI): a review of literature and clinical pearls. Infection 50(4):1007\u20131012","journal-title":"Infection"},{"issue":"7","key":"133_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1590\/0074-02760180111","volume":"113","author":"ML Rodrigues","year":"2018","unstructured":"Rodrigues ML (2018) Neglected disease, neglected populations: the fight against cryptococcus and cryptococcosis. Mem Inst Oswaldo Cruz 113(7):7\u20138","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"133_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011136","volume-title":"Recognition of fungal priority pathogens: What next?","author":"ML Rodrigues","year":"2023","unstructured":"Rodrigues ML, Nosanchuk JD (2023) Recognition of fungal priority pathogens: What next? Public Library of Science, PLoS Negl Trop Dis"},{"key":"133_CR28","doi-asserted-by":"publisher","unstructured":"Rodrigues ML, Nosanchuk JD (2020) Fungal diseases as neglected pathogens: a wake-up call to public health officials. PLoS Negl Trop Dis 14(2):e0007964. https:\/\/doi.org\/10.1371\/journal.pntd.0007964","DOI":"10.1371\/journal.pntd.0007964"},{"key":"133_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S1473-3099(20)30909-9","volume":"21","author":"A Shroufi","year":"2021","unstructured":"Shroufi A, Chiller T, Jordan A, Denning DW, Harrison TS, Govender NP et al (2021) Ending deaths from HIV-related cryptococcal meningitis by 2030. Lancet Infect Dis 21:16\u201318","journal-title":"Lancet Infect Dis"},{"key":"133_CR30","first-page":"169","volume-title":"Parris V","author":"DJ Sloan","year":"2014","unstructured":"Sloan DJ (2014) Parris V. Epidemiology and therapeutic options. Clin Epidemiol. Dove Medical Press Ltd, Cryptococcal meningitis, pp 169\u2013182"},{"key":"133_CR31","unstructured":"World Health Organization. Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. WHO Press. 2022."},{"issue":"1","key":"133_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-4798-1","volume":"20","author":"J Wykowski","year":"2020","unstructured":"Wykowski J, Galagan SR, Govere S, Wallis CL, Moosa MY, Celum C et al (2020) Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100\u2013200 cells\/mm3. BMC Infect Dis 20(1):1\u20136","journal-title":"BMC Infect Dis"}],"container-title":["IMA Fungus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43008-023-00133-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43008-023-00133-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43008-023-00133-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T15:53:26Z","timestamp":1739202806000},"score":1,"resource":{"primary":{"URL":"https:\/\/IMAFungus.biomedcentral.com\/articles\/10.1186\/s43008-023-00133-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,2]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["133"],"URL":"https:\/\/doi.org\/10.1186\/s43008-023-00133-6","relation":{},"ISSN":["2210-6359"],"issn-type":[{"type":"electronic","value":"2210-6359"}],"subject":[],"published":{"date-parts":[[2024,3,2]]},"assertion":[{"value":"8 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript and its content follow all national and international regulations relevant to article writing, interpretation and publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Adherence to national and international regulations"}},{"value":"We, the authors, give our consent for the publication of this manuscript and related content, which include Figs.\u00a0 and , in IMA Fungus.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Marcio Rodrigues is a Senior Editor for IMA Fungus and was not involved in the peer review.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}